AMedP-1.12 medical and dental supply procedures

What it is

What AMedP-1.12 covers

AMedP-1.12 is the NATO Allied Medical Publication that standardises how nations exchange medical and dental property and how they mark medical and pharmaceutical supplies, so that "cross-servicing amongst the Medical Services of the NATO Forces" is possible. In practice that means two things: non-expendable equipment that travels with a patient between nations' care - a stretcher, a ventilator - has to be tracked and returned to whichever nation supplied it, and pharmaceutical or medical supplies have to carry information another nation's medical staff can read and rely on. This page covers what the publication is for, who it addresses, and how it reaches an organisation; it does not reproduce the marking codes or item lists that sit in the document's own clauses.

How it comes to bind

STANAG 2128 is the NATO agreement that gives AMedP-1.12 its force: the agreement of nations to use this publication is recorded in that STANAG, and AMedP-1.12 is the procedure document the STANAG points to. Ratification is a national act, and for a nation that has ratified it, the publication is "effective upon receipt". For an organisation supplying medical or dental materiel into a NATO nation's stock, the practical trigger is a national specification or a defence contract that names AMedP-1.12 or STANAG 2128, not the publication's existence in NATO's catalogue.

Why a common exchange procedure matters

A patient moving through a multinational medical evacuation chain carries equipment that belongs to whichever nation first treated them, and a pharmaceutical supply issued by one nation's medical services may end up read and used by another's. AMedP-1.12 exists so that both of those handoffs work: a common rule for returning non-expendable equipment to its nation of origin, and a common minimum for what a pharmaceutical or medical supply's label has to say, so that storage limits, contents and expiry are legible regardless of which nation packed it. The document also sets a common colour-marking convention for self-injection devices, so that a device's contents can be recognised across nations without relying on a shared language on the label.

Who it addresses, and when it binds

AMedP-1.12 addresses the Medical Services of the NATO Forces, and specifically, in its own words, "each nation providing support of medical material or pharmaceuticals to other nations", who carry the marking and return responsibilities the document sets out. It does not address a supplier or manufacturer directly. In practice, its labelling and marking requirements reach whoever produces or packages medical and dental materiel for a nation's stock once a national specification or contract calls the standard up. Beyond ratification and being "effective upon receipt" for the adopting nation, it says nothing about timing within a procurement programme.

What it requires

AMedP-1.12 is short, organised around one substantive chapter of four clauses.

Exchange procedures (clause 2.1). When a patient transfers between nations, the receiving nation returns non-expendable medical and dental equipment to the nation that supplied it, at the point of transfer where that is possible, or replaces it with equivalent materiel where it is not. Equipment that has to accompany the patient further is returned as soon as possible afterwards, and in the meantime has to be marked in plain text with the supplying nation's identity. Nations arrange property exchange points, staffed by personnel familiar with each other's equipment, at whatever level the operation requires.

Labelling pharmaceutical and medical supplies (clause 2.2). Medical materiel carrying a storage or transport condition has to be marked with that condition. Pharmaceuticals need the generic name and the quantity of contents in metric units on the label, any storage or transport condition beyond the ordinary, and a date of expiry as a minimum, with a production date and lot number expected where possible.

Responsibility of the providing nation (clause 2.3). A nation supplying medical materiel or pharmaceuticals to another nation is responsible for the required storage and transport conditions having held all the way to the point of transfer, not only at the point of dispatch.

Self-injection devices (clause 2.4). The document sets a common colour-marking convention so that a device's contents can be recognised regardless of which nation issued it, with a fluorescent-marking recommendation for low-light conditions, and leaves room for a nation to add further markings under its own legislation on toxic substances.

How it is assessed

AMedP-1.12 names no certification body, no accreditation scheme and no periodic assessment cycle. What the document does describe is national ratification of STANAG 2128; it is silent on how compliance with its own exchange and marking procedures is checked once a nation has ratified. Where an organisation is asked to evidence that its labelling or marking meets clauses 2.1 or 2.2, that happens through whatever national acceptance or contract process invoked the standard, not through any scheme NATO administers or recognises.